Filing Details

Accession Number:
0001179110-21-010543
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-02 17:16:40
Reporting Period:
2021-11-30
Accepted Time:
2021-12-02 17:16:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739104 Elanco Animal Health Inc ELAN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1186033 David R Hoover C/O Elanco Animal Health Incorporated
2500 Innovation Way
Greenfield IN 46140
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-30 10,000 $29.38 105,000 No 4 P Indirect Revocable Trust
Common Stock Acquisiton 2021-11-30 7,307 $0.00 39,267 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Revocable Trust
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Deferred Stock Units Acquisiton 2021-11-30 742 $28.74 742 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,859 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,920 Indirect Suzanne A. Hoover Revocable Trust
Footnotes
  1. Reflects the weighted average price of 10,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on November 30, 2021 with purchase prices ranging from $29.3587 to $29.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
  3. Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
  4. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
  5. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.74 on November 30, 2021.